Clinical trials: Normobaric Hyperoxia
Ischemic Stroke
Normobaric Oxygen in AIS Transferred for EVT
The primary objective of this study is to estimate the efficacy and safety of NBO on 3-month functional outcome after acute ischemic stroke
- Trial name
- AN-O2 (NCT06666764)
- Testing
- NBO, Control
- Where
- 112 sites in China
- Volunteers
- 1,500 people
- Sponsor
- Capital Medical University
Stroke, Endovascular Treatment
Normobaric Hyperoxia Combined With Endovascular Treatment for Acute Ischemic Stroke
The purpose of this study is to evaluate the safety and efficiency of normobaric hyperoxia combined with endovascular treatment for acute ischemic stroke patients with stroke onset 6-24 hours.
- Conditions
- Stroke, Endovascular Treatment, Neuroprotection
- Trial name
- NCT05128422
- Testing
- Normobaric oxygen therapy
- Where
- China
- Volunteers
- 120 people
- Sponsor
- Capital Medical University
Stroke, Acute
Protective Effects of Normobaric Hyperoxia on Blood Brain Barrier in Patients With Acute Ischemic Stroke
The purpose of this study is to find out a serum marker for the evaluation of blood brain barrier damage based on animal experiments and investigate the effect of NBO（Normobaric hyperoxia）on blood brain barrier in the acute…
- Trial name
- NCT02974283
- Testing
- Normobaric oxygen therapy
- Volunteers
- 40 people
- Sponsor
- Capital Medical University
Stroke, Acute, Neuroprotection
Treatment Duration on Normobaric Hyperoxia in Acute Ischemic Stroke
Normoxia Hyperoxia (NBO) is a neuroprotective approach that can be implemented early. NBO is simple and non-invasive and can be used at home or in an ambulance to ensure the shortest possible time after cerebral ischemia occurs.
- Conditions
- Stroke, Acute, Neuroprotection, Endovascular Treatment
- Trial name
- NCT05404373
- Testing
- Normobaric Hyperoxia (NBO), Low flow oxygen
- Where
- China
- Volunteers
- 100 people
- Sponsor
- Capital Medical University
Traumatic Spinal Cord Injuries
Treating Spinal Cord Injury With Early Normobaric Hyperoxia
SpiCoH is a phase IIa, single center, open-label, clinical trial of intermittent normobaric hyperoxia in mechanically ventilated patients with traumatic cervical and/or thoracic spinal cord injury.
- Trial name
- SpiCoH (NCT07465302)
- Testing
- Normobaric Hyperoxia
- Where
- United States
- Volunteers
- 12 people
- Sponsor
- University of Florida